Interestingly, we noted that the response was CD8+ T-cell-dependent, and the injection of MMRd (MLH1 KO) tumor cell lines in mice triggered increased levels of TCR rearrangements in the blood as compared to MMR-proficient tumor cells. This evidence concerns the gene MLH1 and neoplasm.